132 related articles for article (PubMed ID: 4263647)
21. In vitro and in vivo cytotoxicity to EL-4 sarcoma in New Zealand mice.
Gershwin ME; Klingenstein RJ; Chused TM; Steinberg AD
J Immunol; 1974 Dec; 113(6):1968-77. PubMed ID: 4279264
[No Abstract] [Full Text] [Related]
22. The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.
Pels E; den Otter W
Cancer Res; 1974 Nov; 34(11):3089-94. PubMed ID: 4423930
[No Abstract] [Full Text] [Related]
23. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.
Gardner I; Bowern NA; Blanden RV
Eur J Immunol; 1974 Feb; 4(2):63-7. PubMed ID: 4211857
[No Abstract] [Full Text] [Related]
24. Antigen-T lymphocyte interactions: inhibition by cytochalasin B.
Henney CS; Bubbers JE
J Immunol; 1973 Jul; 111(1):85-90. PubMed ID: 4197336
[No Abstract] [Full Text] [Related]
25. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
26. Specific inactivation of cytotoxic lymphocytes after adsorption on 51Cr-labeled fibroblast monolayers.
Ritter J; Lohmann-Matthes ML; Fischer H
Transplantation; 1973 Dec; 16(6):579-82. PubMed ID: 4148250
[No Abstract] [Full Text] [Related]
27. Synergy among thymocytes and peripheral lymph node cells in the in vitro generation of lymphocytes cytotoxic to alloantigens.
Tigelaar RE; Feldmann M
Transplant Proc; 1973 Dec; 5(4):1711-5. PubMed ID: 4272825
[No Abstract] [Full Text] [Related]
28. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
[TBL] [Abstract][Full Text] [Related]
29. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
Rouse BT; Wagner H; Harris AW
J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
[No Abstract] [Full Text] [Related]
30. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants.
Igarashi T; Rodrigues D; Ting CC
J Immunol; 1979 Apr; 122(4):1519-27. PubMed ID: 156217
[TBL] [Abstract][Full Text] [Related]
31. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
Zembala M; Ptak W; Hanczakowska M
Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
[TBL] [Abstract][Full Text] [Related]
32. Arming of macrophages with lymphocytes from mice immunized with tumor tissue.
Horowitz M; Argyris BF
Immunol Commun; 1977; 6(3):297-319. PubMed ID: 69610
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic lymphocytes in Hashimoto's thyroiditis.
Podleski WK
Clin Exp Immunol; 1972 Aug; 11(4):543-8. PubMed ID: 4628576
[TBL] [Abstract][Full Text] [Related]
34. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
Dennert G; Lennox ES
J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
[No Abstract] [Full Text] [Related]
35. Dose and time dependent suppressive and enhancing effect of cytostatics in vitro on the target cell killing activity of lymphocytes.
Petrányi GG; Benczur M; Onódy K; Alföldy P
Folia Biol (Praha); 1973; 19(6):420-3. PubMed ID: 4205080
[No Abstract] [Full Text] [Related]
36. Morphological observations on the contact-induced lysis of target cells.
Koren HS; Ax W; Freund-Moelbert E
Eur J Immunol; 1973 Jan; 3(1):32-7. PubMed ID: 4197969
[No Abstract] [Full Text] [Related]
37. Formation of cytotoxic lymphocytes in mixed leukocyte culture systems: introduction.
Cerottini JC; MacDonald HR; Brunner KT
Transplant Proc; 1973 Dec; 5(4):1621-4. PubMed ID: 4130070
[No Abstract] [Full Text] [Related]
38. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
Howe M; Berman L; Cohen L
J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
[No Abstract] [Full Text] [Related]
39. Accessory cell requirements for the generation of cytolytic T lymphocytes.
Lutz CT; Fitch FW
J Immunol; 1979 Jun; 122(6):2598-604. PubMed ID: 109533
[TBL] [Abstract][Full Text] [Related]
40. Interaction of isoantibody and cytotoxic lymphocytes with allogeneic tumor cells.
Faanes RB; Choi YS
J Immunol; 1974 Jul; 113(1):279-88. PubMed ID: 4208919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
